SAFETY PROFILE OF UPADACITINIB IN PSORIATIC ARTHRITIS: INTEGRATED ANALYSIS FROM TWO PHASE 3 TRIALS

被引：0

作者：

Burmester, Gerd ^{[1
]}

Winthrop, Kevin ^{[2
]}

Nash, Peter ^{[3
]}

Goupille, Philippe ^{[4
,5
]}

Azevedo, Valderilio F. ^{[6
]}

Salvarani, Carlo ^{[7
,8
]}

McCaskill, Reva M. ^{[9
]}

Liu, John ^{[9
]}

Pierre-Louis, Bosny J. ^{[9
]}

Anderson, Jaclyn K. ^{[9
]}

Ruderman, Eric ^{[10
]}

机构：

[1] Charite, Berlin, Germany

[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[3] Griffith Univ, Brisbane, Qld, Australia

[4] Univ Hosp, Tours, France

[5] CIC1415, Tours, France

[6] Univ Fed Parana, Curitiba, Parana, Brazil

[7] Azienda USL IRCCS Reggio Emilia, Reggio Emilia, Italy

[8] Univ Modena & Reggio Emilia, Reggio Emilia, Italy

[9] AbbVie Inc, N Chicago, IL USA

[10] Northwestern Univ, Chicago, IL 60611 USA

来源：

INTERNAL MEDICINE JOURNAL | 2021年 / 51卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P105

引用

页码：46 / 46

页数：1

共 50 条

[1] Safety Profile of Upadacitinib in Psoriatic Arthritis: Integrated Analysis from Two Phase 3 Trials
Burmester, Gerd
Winthrop, Kevin
Nash, Peter
Goupille, Philippe
Azevedo, Valderilio F.
Salvarani, Carlo
McCaskill, Reva M.
Liu, John
Pierre-Louis, Bosny J.
Anderson, Jaclyn K.
Ruderman, Eric
[J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
[2] Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
Gerd R. Burmester
Kevin Winthrop
Ricardo Blanco
Peter Nash
Philippe Goupille
Valderilio F. Azevedo
Carlo Salvarani
Andrea Rubbert-Roth
Elizabeth Lesser
Ralph Lippe
Apinya Lertratanakul
Reva M. Mccaskill
John Liu
Eric M. Ruderman
[J]. Rheumatology and Therapy, 2022, 9 : 521 - 539
[3] Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
Burmester, Gerd R.
Winthrop, Kevin
Blanco, Ricardo
Nash, Peter
Goupille, Philippe
Azevedo, Valderilio F.
Salvarani, Carlo
Rubbert-Roth, Andrea
Lesser, Elizabeth
Lippe, Ralph
Lertratanakul, Apinya
Mccaskill, Reva M.
Liu, John
Ruderman, Eric M.
[J]. RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 521 - 539
[4] Safety Profile of Upadacitinib Up to 3 Years in Patients with Psoriatic Arthritis: An Integrated Analysis from the Phase 3 Program
Gerd, Burmester R.
Kevin, Winthrop
Ricardo, Blanco
Peter, Nash
Philippe, Goupille
Valderilio, Azevedo F.
Carlo, Salvarini
Andrea, Rubbert-Roth
Elizabeth, Lesser
Reva, Mccaskill M.
John, Liu
Bosny, Pierre-Louis J.
Sandra, Walko
Ralph, Lippe
Apinya, Lertratanakul
Eric, Ruderman M.
[J]. SWISS MEDICAL WEEKLY, 2021, 151 : S26 - S26
[5] SAFETY PROFILE OF UPADACITINIB UP TO 3 YEARS IN PATIENTS WITH PSORIATIC ARTHRITIS: AN INTEGRATED ANALYSIS FROM THE PHASE 3 PROGRAM
Burmester, G. R.
Winthrop, K.
Blanco, R.
Nash, P.
Goupille, P.
Azevedo, F.
Salvarani, C.
Rubbert-Roth, A.
Lesser, E.
Mccaskill, R.
Liu, J.
Pierre-Louis, B.
Walko, S.
Lippe, R.
Lertratanakul, A.
Ruderman, E.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1287 - 1288
[6] SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAMME
Cohen, Stanley B.
van Vollenhoven, Ronald
Winthrop, Kevin
Zerbini, Cristiano
Tanaka, Yoshiya
Bessette, Louis
Zhang, Ying
Khan, Nasser
Hendrickson, Barbara
Enejosa, Jeffrey V.
Burmester, Gerd Rudiger
[J]. RHEUMATOLOGY, 2020, 59 : 96 - 96
[7] SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM
Cohen, Stanley B.
van Vollenhoven, Ronald
Winthrop, Kevin
Zerbini, Cristiano
Tanaka, Yoshiya
Bessette, Louis
Li Yihan
Khan, Nasser
Hendrickson, Barbara
Burmester, Gerd Ruediger
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 357 - 357
[8] SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM
Cohen, Stanley B.
van Vollenhoven, Ronald
Winthrop, Kevin
Zerbini, Cristiano A. F.
Tanaka, Yoshiya
Bessette, Louis
Zhang, Ying
Khaff, Nasser
Hendrickson, Barbara
Enejosa, Jeffrey V.
Burmesters, Gerd
[J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 10 - 10
[9] Safety Profile of Upadacitinib in Rheumatoid Arthritis: Integrated Analysis from the SELECT Phase 3 Clinical Program
Cohen, Stanley
van Vollenhoven, Ronald
Winthrop, Kevin
Zerbini, Cristiano A.
Tanaka, Yoshiya
Bessette, Louis
Zhang, Ying
Khan, Nasser
Hendrickson, Barbara
Enejosa, Jose Jeffrey
Burmester, Gerd
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[10] CHARACTERIZATION OF REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: POST-HOC ANALYSIS FROM TWO PHASE 3 TRIALS
Mease, P. J.
Kavanaugh, A.
Gladman, D. D.
Fitzgerald, O.
Soriano, E.
Nash, P.
Feng, D.
Lertratanakul, A.
Douglas, K.
Lippe, R.
Gossec, L.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1294 - 1295

← 1 2 3 4 5 →